ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects

July 4, 1986

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

House Subcommittee Rejects Doubling Budget For Cancer Research, Provides Increase To NIH

July 17, 2009

Toxicity Testing Reorganization Announced; Rall To Head It Up

November 17, 1978

Regulatory Agencies Get Data For Action Against One Of World’s Most Widely Used Carcinogens

October 6, 1978